logo
Select company
Select metric
$ -15.3MEarning Before Interest & Taxes (EBIT)
VS
Market
27
Sector
58
Industry
72
History
43
$ 0.7Close
$ 0.18 - $ 1.57 52-Week Range
Ticker Information

Ticker

PSTV

Company Name

PLUS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PLUS THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PSTV - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -15.3M
3/31/2025$ -19.67M
12/31/2024$ -9.25M
9/30/2024$ -9.16M
6/30/2024$ -9.47M
3/31/2024$ -11.48M
12/31/2023$ -12.92M
9/30/2023$ -14.67M
6/30/2023$ -16.59M
3/31/2023$ -20.32M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PLUS THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -2.54M.
  • Over the past 5 years, PLUS THERAPEUTICS INC's average EBIT has been $ -12.97M.
  • The median EBIT for PLUS THERAPEUTICS INC during this period was $ -12.69M
  • PLUS THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ -2.54M.
  • The lowest EBIT recorded by PLUS THERAPEUTICS INC in the same timeframe $ -20.32M

PLUS THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
OVID : OVID THERAPEUTICS INC $ -38.18MVERU : VERU INC $ -32.09MALGS : ALIGOS THERAPEUTICS INC $ -61.46MCBUS : CIBUS INC $ -241.12MSTTK : SHATTUCK LABS INC $ -61.51MDYAI : DYADIC INTERNATIONAL INC $ -5.09MCUE : CUE BIOPHARMA INC $ -38.38MMRKR : MARKER THERAPEUTICS INC $ -14.56MDTIL : PRECISION BIOSCIENCES INC $ -76.89MPYXS : PYXIS ONCOLOGY INC $ -98.17M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

PSTV - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -20.32M

Minimum

Mar 31, 2023

$ -2.54M

Maximum

Sep 30, 2020

$ -12.97M

Average

$ -12.69M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.79M with a standard deviation of $ 130.84M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.79M
median$ 971K
std$ 130.84M